申请人:Ali Amjad
公开号:US20100249024A1
公开(公告)日:2010-09-30
Compounds of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula 1, A
1
and A2 are each an aromatic ring, a 5-6-membered heterocyclic ring, an aromatic ring fused to a heterocyclic ring, a phenyl ring fused to a heterocyclic ring, or a cycloalkyl ring.
公式I的化合物,包括该化合物的药用可接受盐,是CETP抑制剂,可用于提高高密度脂蛋白胆固醇,降低低密度脂蛋白胆固醇,并用于治疗或预防动脉硬化。在公式I的化合物中,A1和A2分别是芳香环、5-6元杂环、芳香环与杂环融合、苯环与杂环融合或环状烷基环。